All Stories

  1. Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry

    Article • PLoS ONE, June 2022, PLOS

    Professor Andreas Geier

  2. Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease

    Article • United European Gastroenterology Journal, September 2018, SAGE Publications

    Professor Andreas Geier

  3. Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study

    Article • Scandinavian Journal of Gastroenterology, September 2018, Taylor & Francis

    Professor Andreas Geier, Dr. Lanja Saleh

  4. Emerging therapies for NASH - the future is now

    Article • Expert Review of Clinical Pharmacology, April 2017, Taylor & Francis

    Professor Andreas Geier

  5. Nicht-alkoholische Fettlebererkrankung (NAFLD)

    Article • DMW - Deutsche Medizinische Wochenschrift, July 2015, Thieme Publishing Group

    Professor Andreas Geier

  6. Effect of drug transporter pharmacogenetics on cholestasis

    Article • Expert Opinion on Drug Metabolism & Toxicology, September 2014, Informa Healthcare

    Professor Andreas Geier

  7. Hepatitis B virus: The “metabolovirus” highjacks cholesterol and bile acid metabolism

    Article • Hepatology, July 2014, Wolters Kluwer Health

    Professor Andreas Geier